Thymic & Immune Research Guide

Thymosin Alpha-1: Mechanism, Handling & Research Guide

Also known as: Thymosin Alpha-1, Thymosin alpha 1, Talpha1, Ta1, Thymalfasin, Thymosin Fraction 5 alpha-1, Zadaxin, TA1, CAS 62304-98-7

Key Facts

Thymosin Alpha-1 is a thymic & immune research peptide (C129H215N33O55, MW 3108.315 g/mol). Natural immune regulator for T-cell maturation and infection research. It is supplied as a lyophilized powder for laboratory and in-vitro research use only — not for human consumption.

Classification	Thymic peptide immunomodulator (28-amino-acid biological response modifier)
Molecular Formula	C129H215N33O55
Molecular Weight	3108.315 g/mol
CAS Number	62304-98-7
Research Half-Life	Reported plasma half-life approximately 2 hours in pharmacokinetic literature for the synthetic form (thymalfasin); values vary by model and assay
Form	Lyophilized powder
Research Category	Thymic & Immune

What is Thymosin Alpha-1?

Thymosin Alpha-1 (Ta1) is a 28-amino acid peptide naturally derived from prothymosin alpha in the thymus gland, playing a critical role in immune system maturation and regulation. It functions as a biological response modifier, enhancing T-cell differentiation from bone marrow stem cells, promoting dendritic cell maturation, and augmenting natural killer cell cytotoxicity. Ta1 activates toll-like receptors (TLR2 and TLR9), stimulating both innate and adaptive immune pathways. Thymosin Alpha-1 has been among the most clinically studied peptides in immunology. Research published in the Annals of the New York Academy of Sciences by Garaci et al. demonstrated that Ta1 modulated immune reconstitution in immunocompromised subjects. A pivotal study by Andreone et al. (2001) in Gut showed that Ta1 produced sustained virological responses in chronic hepatitis B comparable to interferon-alpha, with significantly fewer adverse effects. Studies in Critical Care Medicine indicated that Ta1 use in sepsis models improved survival rates and reduced inflammatory biomarkers, leading to its adoption in clinical sepsis studies in several countries. Compared to thymulin and Thymalin, which are also thymus-derived peptides, Thymosin Alpha-1 has the most extensive clinical evidence base. Thymulin primarily affects T-cell differentiation through zinc-dependent mechanisms, while Ta1 has broader immunomodulatory reach including dendritic cell activation. Unlike synthetic immunostimulants such as levamisole, Ta1 modulates rather than simply stimulates immunity, reducing the risk of autoimmune overstimulation. Store lyophilized Thymosin Alpha-1 at -20°C. Reconstitute with bacteriostatic water and refrigerate at 2-8°C, using within 4 weeks. This peptide is studied by immunologists, oncology researchers investigating adjuvant immunotherapy, and infectious disease specialists working on hepatitis and sepsis treatment strategies.

Thymosin Alpha-1 Research Applications

In published and preclinical research, Thymosin Alpha-1 has been studied across the following areas:

Immunomodulation and T-cell research
Sepsis-model immunology research
Hepatitis B and C research
Cancer immunotherapy studies

Thymosin Alpha-1 in Research: Study Context

Published literature characterizes Thymosin Alpha-1 as a thymus-derived 28-amino-acid peptide that modulates innate and adaptive immunity, primarily through Toll-like receptor signaling (notably TLR2/TLR9 via MyD88), dendritic-cell maturation, T-cell differentiation, and induction of indoleamine 2,3-dioxygenase, positioning it as a regulator of inflammation and immune tolerance rather than a simple stimulant (Romani et al., 2007; Bonifazi et al., 2010). For in-vitro and laboratory research use only - not FDA-approved and no human concentration is provided here. Reconstitute the lyophilized 10mg peptide with bacteriostatic water to a defined concentration of 5.0 mg/mL for laboratory handling, and validate identity and purity against the primary literature and the lot-specific Certificate of Analysis (COA) before any experimental use.

How Thymosin Alpha-1 Compares

Researchers frequently evaluate Thymosin Alpha-1 alongside related compounds:

Thymosin Alpha-1 vs Thymalin — Thymalin is a multi-component thymic polypeptide extract giving broad, less-defined immune modulation; Thymosin Alpha-1 is a single, sequence-defined 28-mer with a more specific TLR/dendritic-cell mechanism and a larger clinical literature.

Thymosin Alpha-1 — Frequently Asked Questions

What receptor pathways does Thymosin Alpha-1 engage in published research models?

In published immunology literature, Thymosin Alpha-1 is reported to signal through Toll-like receptors - particularly TLR2 and TLR9 via the MyD88 adaptor - driving dendritic-cell maturation, modulating T-cell differentiation, and inducing indoleamine 2,3-dioxygenase activity. These pathways are described in research models only; this characterization is provided for laboratory research and does not constitute a therapeutic claim.

Is Thymosin Alpha-1 FDA-approved?

No. While a synthetic derivative (thymalfasin/Zadaxin) is registered in some countries, the material supplied here is for laboratory research use only and is not FDA-approved for human use. Researchers should reference the primary literature and confirm material identity and purity against the lot Certificate of Analysis (COA).

How well characterized is its half-life?

Pharmacokinetic studies of the synthetic form report a plasma half-life on the order of about 2 hours, though reported values vary with species, assay, and study design. For research purposes, characterize stability empirically in your own system rather than relying on a single literature value.

Is Thymosin Alpha-1 legal to buy for research?

Thymosin Alpha-1 is sold in the United States as a research chemical for laboratory and in-vitro use only. It is not approved by the FDA for human use and is not sold for human consumption. Researchers are responsible for compliance with all applicable federal, state, and institutional regulations.

Does Thymosin Alpha-1 come with a Certificate of Analysis?

Yes. Every batch of Thymosin Alpha-1 from Elyte Peptides ships with a third-party Certificate of Analysis (COA) documenting identity and HPLC purity (≥98%), so research results can be traced to a verified lot.

What is Thymosin Alpha-1 and how does it work?

Thymosin Alpha-1 (Ta1) is a 28-amino acid peptide originally isolated from the thymus gland. It functions as an immune regulator by promoting T-cell maturation and differentiation, activating dendritic cells and natural killer cells, and enhancing Toll-like receptor (TLR) signaling. It upregulates MHC class I expression, improving the immune system's ability to recognize and target infected or abnormal cells in research models.

What research has been done on Thymosin Alpha-1?

Thymosin Alpha-1 is approved in over 35 countries (as Zadaxin) for hepatitis B and as an immune adjuvant. Published research in the Journal of Immunology demonstrated its role in dendritic cell maturation and TLR9 signaling. Clinical studies showed improved survival rates in severe sepsis patients. Additional research has explored its efficacy as an adjuvant in cancer immunotherapy and its ability to restore immune function in immunocompromised models.

How does Thymosin Alpha-1 compare to Thymalin?

Both are thymus-derived immune peptides but differ in specificity. Thymosin Alpha-1 is a single, well-characterized 28-amino acid peptide with a defined mechanism through TLR and MHC pathways. Thymalin is a polypeptide extract containing a mixture of thymic factors, providing broader but less specific immune modulation. Thymosin Alpha-1 has more extensive clinical data and international approvals compared to Thymalin.

Research References

All research guides